| Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) (NCT01395914) | Helsinn Therapeutics (U.S.), Inc | 2011-07-01 |
| ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer (NCT01360554) | Pfizer | 2011-06-16 |
| Combined Application of EBUS and EUS in Lung Cancer (NCT01385111) | National Cancer Center, Korea | 2011-06-01 |
| Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer (NCT01426620) | University of Louisville | 2011-06-01 |
| Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer (NCT01480973) | University Health Network, Toronto | 2011-06-01 |
| Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer (NCT01404260) | Guangdong Association of Clinical Trials | 2011-06-01 |
| A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer (NCT01380769) | NewLink Genetics Corporation | 2011-06-01 |
| Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer (NCT01350817) | University Hospital, Limoges | 2011-06-01 |
| A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy (NCT01364012) | Hoffmann-La Roche | 2011-05-23 |
| Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer (NCT01527864) | Protgen Ltd | 2011-05-01 |
| Comparison of Diagnostic and Therapeutic Efficacy of EBUS-TBNA/EUS-FNA and TEMLA in Operable NSCLC. (NCT03188562) | Pulmonary Hospital Zakopane | 2011-05-01 |
| Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT01390818) | EMD Serono | 2011-05-01 |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies (NCT01401907) | Massachusetts General Hospital | 2011-05-01 |
| Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4 (NCT01726309) | Cancer Trials Ireland | 2011-05-01 |
| A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer (NCT01362400) | Infinity Pharmaceuticals, Inc. | 2011-05-01 |
| Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer (NCT01297491) | Novartis Pharmaceuticals | 2011-05-01 |
| A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer (NCT01409681) | University of Michigan Rogel Cancer Center | 2011-05-01 |
| Chemotherapy for Lung Cancer in HIV-positive Patients (NCT01296113) | Intergroupe Francophone de Cancerologie Thoracique | 2011-05-01 |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NCT01259089) | Northwestern University | 2011-04-27 |
| Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene (NCT01221077) | Astellas Pharma Inc | 2011-04-08 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer (NCT01379976) | Mario Negri Institute for Pharmacological Research | 2011-04-01 |
| Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer (NCT01287962) | Sun Yat-sen University | 2011-04-01 |
| An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System (NCT02067858) | Steven Burton | 2011-04-01 |
| Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) (NCT01669707) | Beijing Chest Hospital | 2011-04-01 |
| Maintenance Gemcitabine in the Chinese Advanced Lung Cancer (NCT01336192) | Tongji University | 2011-04-01 |
| A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck (NCT01059643) | Eli Lilly and Company | 2011-04-01 |
| Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) (NCT01327612) | Amgen | 2011-03-03 |
| Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation. (NCT01217619) | Baohui Han | 2011-03-02 |
| A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression (NCT01230710) | Hoffmann-La Roche | 2011-03-01 |
| A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations (NCT01342965) | Hoffmann-La Roche | 2011-03-01 |
| Exercise Study in Patients With Lung Cancer (NCT01581346) | German Cancer Research Center | 2011-03-01 |
| A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors (NCT00455052) | Mersana Therapeutics | 2011-03-01 |
| Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer (NCT02549261) | Biotech Pharmaceutical Co., Ltd. | 2011-03-01 |
| Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC) (NCT01207063) | Maastricht Radiation Oncology | 2011-03-01 |
| Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients (NCT01393080) | Tianjin Medical University Cancer Institute and Hospital | 2011-03-01 |
| Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer (NCT01577654) | Endocyte | 2011-03-01 |
| Understanding Mechanisms of Acquired Resistance to BIBW2992 (NCT01074177) | Massachusetts General Hospital | 2011-02-01 |
| Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy (NCT02055144) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2011-02-01 |
| Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer (NCT01263886) | Sanofi | 2011-02-01 |
| Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK) (NCT01662635) | Instituto Nacional de Cancerologia de Mexico | 2011-02-01 |
| A Study in Non Small Cell Lung Cancer (NCT01139775) | Eli Lilly and Company | 2011-02-01 |
| Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. (NCT01291017) | University of Florida | 2011-02-01 |
| A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) (NCT01466647) | Axelar AB | 2011-01-01 |
| Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer (NCT01171170) | Dutch Society of Physicians for Pulmonology and Tuberculosis | 2011-01-01 |
| A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer (NCT01770795) | Gachon University Gil Medical Center | 2011-01-01 |
| Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography (NCT01347424) | Sun Yat-sen University | 2011-01-01 |
| A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer (NCT01268059) | MedImmune LLC | 2010-12-16 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| Lung Cancer Rehabilitation Study (NCT01258478) | University Hospital, Geneva | 2010-12-01 |
| Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer (NCT01540045) | Instituto Nacional de Cancerologia de Mexico | 2010-12-01 |
| A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy (NCT01168973) | Eli Lilly and Company | 2010-12-01 |
| Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01424709) | Tongji University | 2010-12-01 |
| Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer (NCT01222572) | Dana-Farber Cancer Institute | 2010-12-01 |
| Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects (NCT01134016) | Golden Biotechnology Corporation | 2010-12-01 |
| A Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage Non Small Cell Lung Cancer (NCT01237171) | IsoRay Medical, Inc. | 2010-11-01 |
| A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer (NCT01165021) | Eli Lilly and Company | 2010-11-01 |
| Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel (NCT01234038) | Ionis Pharmaceuticals, Inc. | 2010-11-01 |
| Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies (NCT01242072) | Alaunos Therapeutics | 2010-11-01 |
| Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium. (NCT01260038) | University Hospital, Antwerp | 2010-11-01 |
| BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC (NCT01243775) | Chonnam National University Hospital | 2010-11-01 |
| Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 (NCT01383135) | Stanford University | 2010-10-01 |
| BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC (NCT01156545) | National Cancer Center, Korea | 2010-10-01 |
| A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer). (NCT01153399) | AstraZeneca | 2010-10-01 |
| A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) (NCT01183858) | Hoffmann-La Roche | 2010-10-01 |
| Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01211002) | Simcere Pharmaceutical Co., Ltd | 2010-10-01 |
| A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. (NCT01124864) | Novartis Pharmaceuticals | 2010-10-01 |
| A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer (NCT01188707) | Herlev Hospital | 2010-10-01 |
| A Retrospective Study to Investigate the Current Situation of Biopsy Testing in Swedish Inoperable Non Small Cell Lung Cancer (NSCLC) Patients (NCT01139619) | AstraZeneca | 2010-10-01 |
| Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT01210053) | Third Military Medical University | 2010-09-01 |
| Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma (NCT01167972) | AstraZeneca | 2010-09-01 |
| Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer (NCT01212627) | Angela Taber MD | 2010-09-01 |
| Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound (NCT01206894) | Centre hospitalier de l'Université de Montréal (CHUM) | 2010-09-01 |
| Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC) (NCT01147211) | National Taiwan University Hospital | 2010-09-01 |
| Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer (NCT01165216) | Bristol-Myers Squibb | 2010-09-01 |
| To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01185314) | AstraZeneca | 2010-09-01 |
| A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC) (NCT01225302) | AbbVie | 2010-09-01 |
| A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer (NCT01189968) | OncoMed Pharmaceuticals, Inc. | 2010-09-01 |
| Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients (NCT01136083) | National Taiwan University Hospital | 2010-09-01 |
| Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer (NCT00932152) | University of Pittsburgh | 2010-09-01 |
| Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer (NCT01038752) | Optimum Therapeutics, LLC | 2010-08-01 |
| A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer (NCT01121575) | Pfizer | 2010-08-01 |
| The Effect Of Aspirin On Survival in Lung Cancer (NCT01058902) | Liverpool Heart and Chest Hospital NHS Foundation Trust | 2010-08-01 |
| Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation (NCT01182155) | Stanford University | 2010-08-01 |
| Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC (NCT02497118) | Tianjin Medical University Cancer Institute and Hospital | 2010-08-01 |
| Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (NCT01187290) | Shanghai Jiao Tong University School of Medicine | 2010-08-01 |
| A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology (NCT01106781) | AstraZeneca | 2010-08-01 |
| Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC) (NCT01258127) | Shanghai Nancy Medical Sci-Tech Co. Ltd | 2010-08-01 |
| Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma (NCT01177397) | Celgene | 2010-07-20 |
| Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies (NCT01165658) | M.D. Anderson Cancer Center | 2010-07-16 |
| Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients (NCT01172314) | Texas A&M University | 2010-07-13 |
| Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer (NCT01510405) | Dartmouth-Hitchcock Medical Center | 2010-07-01 |
| A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors (NCT01171924) | Curis, Inc. | 2010-07-01 |
| Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer (NCT01126736) | Eisai Inc. | 2010-06-10 |
| MEK Inhibitor and Thoracic Radiotherapy Trial (NCT01146756) | The Christie NHS Foundation Trust | 2010-06-04 |
| Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients (NCT01046383) | Immunotec Inc. | 2010-06-01 |
| Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC (NCT01042288) | SCRI Development Innovations, LLC | 2010-06-01 |
| GWAS Research of Lung Cancer in Tianjin (NCT01255059) | Tianjin Medical University Cancer Institute and Hospital | 2010-06-01 |
| Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer (NCT01138163) | Peregrine Pharmaceuticals | 2010-06-01 |
| Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer (NCT01163058) | Istituto Clinico Humanitas | 2010-06-01 |